Literature DB >> 27069545

A novel rat model of heart failure induced by high methionine diet showing evidence of association between hyperhomocysteinemia and activation of NF-kappaB.

Bin Liu1, Shengting Ma1, Tao Wang1, Chengjun Zhao1, Yi Li1, Jie Yin1, Cuixia Liu1, Chengzhi Gao1, Ling Sun1, Wenwei Yue1, Huapeng Yu1, Ruyi Jia1.   

Abstract

Heart failure is one of the most serious diseases worldwide, and can be caused by many factors, among them hyperhomocysteinemia can increase the risk for development of heart failure. In this study, we treated rats with high methionine diet (HMD), which can be conversed to homocysteine in human body, to induce a novel model of heart failure. We proved the successful establishment of this model by echocardiography and pathological evaluation at the termination of treatment. Ejection fraction and fractional shortening were significantly deceased after HMD treatment, while left ventricular volume in systole was increased. HMD treatment caused hypertrophy of cardiomyocytes, disarrangement of myofibers, and infiltration of inflammatory cells, as well as abundant apoptotic cells appeared after HMD treatment. Plasmatic homocysteine level was elevated after HMD treatment. Furthermore, through electrophoretic mobility shift assay and chromatin immunoprecipitation, the activity of NF-κB in nuclear extract was also significantly elevated, showing evidence of positive relationship between hyperhomocysteinemia and activation of NF-κB in HMD-induced heart failure. The successful development and validation of this model have made it a new tool for translational medical research of metabolic disorders-related cardiovascular disease.

Entities:  

Keywords:  Heart failure; NF-kappaB; high methionine diet; hyperhomocysteinemia; rat model

Year:  2016        PMID: 27069545      PMCID: PMC4759421     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  32 in total

Review 1.  Animal models of heart failure: a scientific statement from the American Heart Association.

Authors:  Steven R Houser; Kenneth B Margulies; Anne M Murphy; Francis G Spinale; Gary S Francis; Sumanth D Prabhu; Howard A Rockman; David A Kass; Jeffery D Molkentin; Mark A Sussman; Walter J Koch; Walter Koch
Journal:  Circ Res       Date:  2012-05-17       Impact factor: 17.367

Review 2.  IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

Authors:  Jun-Li Luo; Hideaki Kamata; Michael Karin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C.

Authors:  G Wang; Y L Siow; K O
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease.

Authors:  S W Cheng; A C Ting; J Wong
Journal:  Ann Vasc Surg       Date:  1997-05       Impact factor: 1.466

5.  Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure.

Authors:  Tariq Hamid; Shang Z Guo; Justin R Kingery; Xilin Xiang; Buddhadeb Dawn; Sumanth D Prabhu
Journal:  Cardiovasc Res       Date:  2010-08-25       Impact factor: 10.787

6.  Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart.

Authors:  C Li; W Browder; R L Kao
Journal:  Am J Physiol       Date:  1999-02

7.  Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway.

Authors:  Chih-Hsin Tang; Yung-Cheng Chiu; Tzu-Wei Tan; Rong-Sen Yang; Wen-Mei Fu
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

Review 8.  Animal models of human cardiovascular disease, heart failure and hypertrophy.

Authors:  G Hasenfuss
Journal:  Cardiovasc Res       Date:  1998-07       Impact factor: 10.787

9.  Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction.

Authors:  Ramachandran S Vasan; Alexa Beiser; Ralph B D'Agostino; Daniel Levy; Jacob Selhub; Paul F Jacques; Irwin H Rosenberg; Peter W F Wilson
Journal:  JAMA       Date:  2003-03-12       Impact factor: 56.272

10.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  5 in total

1.  Influence of renal function on the association between homocysteine level and risk of ischemic stroke.

Authors:  Yao Cheng; Fan-Zhen Kong; Xiao-Feng Dong; Qin-Rong Xu; Qian Gui; Wei Wang; Hong-Xuan Feng; Wei-Feng Luo; Zong-En Gao; Guan-Hui Wu
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 2.  Homocysteine and psoriasis.

Authors:  Xiran Lin; Xianmin Meng; Zhiqi Song
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

3.  Effect of Methionine Diet on Metabolic and Histopathological Changes of Rat Hippocampus.

Authors:  Maria Kovalska; Petra Hnilicova; Dagmar Kalenska; Barbara Tothova; Marian Adamkov; Jan Lehotsky
Journal:  Int J Mol Sci       Date:  2019-12-10       Impact factor: 5.923

4.  Effect of Methionine Diet on Time-Related Metabolic and Histopathological Changes of Rat Hippocampus in the Model of Global Brain Ischemia.

Authors:  Maria Kovalska; Petra Hnilicova; Dagmar Kalenska; Anna Tomascova; Marian Adamkov; Jan Lehotsky
Journal:  Biomolecules       Date:  2020-07-30

5.  Effects of Hyperhomocysteinemia on the Platelet-Driven Contraction of Blood Clots.

Authors:  Rustem I Litvinov; Alina D Peshkova; Giang Le Minh; Nail N Khaertdinov; Natalia G Evtugina; Guzel F Sitdikova; John W Weisel
Journal:  Metabolites       Date:  2021-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.